The α7 nicotinic acetylcholine receptor agonist, A-582941, regulates GSK3β and tau phosphorylation:: Potential for disease modification in Alzheimer's disease

被引:0
|
作者
Nikkel, A. L. [1 ]
Markosyan, S. [1 ]
Martino, B. [1 ]
Gubbins, E. [1 ]
Li, J. [1 ]
Han, E. K. [1 ]
Luo, Y. [1 ]
Hu, M. [1 ]
Puttfarcken, P. [1 ]
Decker, M. [1 ]
Gopalakrishnan, M. [1 ]
Bitner, R. S. [1 ]
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:SMA28 / SMA29
页数:2
相关论文
共 50 条
  • [1] GSK3β and Tau Protein in Alzheimer's Disease and Epilepsy
    Toral-Rios, Danira
    Pichardo-Rojas, Pavel S.
    Alonso-Vanegas, Mario
    Campos-Pena, Victoria
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [2] GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease- like filaments
    Chakraborty, Pijush
    Purslow, Jeffrey A.
    Fromm, Simon A.
    Chatterjee, Debdeep
    Zachrdla, Milan
    Zhuang, Shannon
    Puri, Sambhavi
    Wolozin, Benjamin
    Zweckstetter, Markus
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (52)
  • [3] GSK3 and Tau: Two Convergence Points in Alzheimer's Disease
    Hernandez, Felix
    Lucas, Jose J.
    Avila, Jesus
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S141 - S144
  • [4] GRK5 influences the phosphorylation of tau via GSK3 and contributes to Alzheimer's disease
    Zhao, Jianghao
    Li, Xiaohui
    Chen, Xiongjin
    Cai, Yujie
    Wang, Yan
    Sun, Wenjing
    Mai, Hui
    Yang, Jingqi
    Fan, Weihao
    Tang, Pei
    Ou, Mingqian
    Zhang, Yuan
    Huang, Xuemei
    Zhao, Bin
    Cui, Lili
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 10411 - 10420
  • [5] The GSK3 hypothesis of Alzheimer's disease
    Hooper, Claudie
    Killick, Richard
    Lovestone, Simon
    JOURNAL OF NEUROCHEMISTRY, 2008, 104 (06) : 1433 - 1439
  • [6] The selective α7 nicotinic acetylcholine receptor agonist A-582941 activates immediate early genes in limbic regions of the forebrain:: Differential effects in the juvenile and adult rat
    Thomsen, M. S.
    Mikkelsen, J. D.
    Timmermann, D. B.
    Peters, D.
    Hay-Schmidt, A.
    Martens, H.
    Hansen, H. H.
    NEUROSCIENCE, 2008, 154 (02) : 741 - 753
  • [7] GSK3 signaling regulates app processing and Aβ production and its pharmaceutical potential for alzheimer's disease
    Song, W.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 10 - 11
  • [8] The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease
    Sabbagh, Marwan N.
    Lukas, Ronald J.
    Sparks, D. Larry
    Reid, Richard T.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (04) : 317 - 325
  • [9] Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease
    Singh, Sushma
    Agrawal, Neetu
    Goyal, Ahsas
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (03) : 384 - 394
  • [10] α7 Nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease
    Carson, R.
    Craig, D.
    McGuinness, B.
    Johnston, J. A.
    O'Neill, F. A.
    Passmore, A. P.
    Ritchie, C. W.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (04) : 244 - 248